Patients’ prognoses are related to their risk of relapse which can be:
- Low risk
- Intermediate risk
- High risk
Chromosomes/genes abnormalities of patients affect two thirds of their prognosis. The final third is determined by age, sex, physical fitness and clinical features .
- Identifying patients’ risk for relapse helps determine:
- Suitable treatments and intensity of treatment required
- Appropriate consolidation therapy, including suitability for ASCT